$12.70
0.07[0.55%]
At close: Apr 26
$12.70
0[0.00%]
PreMarket: 7:40PM EDT
Cidara Therapeutics
(NASDAQ:CDTX)Cidara Therapeutics Stock (NASDAQ:CDTX), Insider Trading Activity
Cidara Therapeutics: Insider buying and selling updated today.
Shares Outstanding
4.562M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -21.029K | $0.67 | -$14.09K | SELL | -7.48% | 260.165K | Mar 11 | View |
| Mar 12, 2024 | Taylor Sandison | CHIEF MEDICAL OFFICER | -20.662K | $0.67 | -$13.84K | SELL | -5.62% | 347.095K | Mar 11 | View |
| Mar 12, 2024 | Shane Ward | COO & CLO | -20.473K | $0.67 | -$13.71K | SELL | -9.34% | 198.77K | Mar 11 | View |
| Mar 12, 2024 | Preetam Shah | CFO & CBO | -18.931K | $0.67 | -$12.68K | SELL | -7.69% | 227.21K | Mar 11 | View |
| Sep 13, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -18.469K | $0.95 | -$17.51K | SELL | -6.25% | 277.194K | Sep 11 | View |
| Sep 13, 2023 | Taylor Sandison | CHIEF MEDICAL OFFICER | -18.793K | $0.95 | -$17.81K | SELL | -4.91% | 363.757K | Sep 11 | View |
| Aug 14, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | 10K | $0.97 | $9.70K | BUY | 3.50% | 295.663K | Aug 14 | View |
| Aug 08, 2023 | Jeffrey Stein | PRESIDENT & CEO | 50K | $0.96 | $47.88K | BUY | 15.45% | 373.611K | Aug 08 | View |
| Mar 27, 2023 | Jeffrey Stein | PRESIDENT & CEO | 50K | $1.04 | $51.85K | BUY | 18.27% | 323.611K | Mar 27 | View |
| Mar 13, 2023 | Shane Ward | COO & CLO | -4.329K | $1.53 | -$6.62K | SELL | -4.87% | 84.576K | Mar 13 | View |
| Mar 13, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -7.562K | $1.53 | -$11.57K | SELL | -3.80% | 191.663K | Mar 13 | View |
| Mar 13, 2023 | Preetam Shah | CFO & CBO | -6.648K | $1.53 | -$10.17K | SELL | -4.29% | 148.141K | Mar 13 | View |
| Mar 13, 2023 | Taylor Sandison | CHIEF MEDICAL OFFICER | -7.203K | $1.53 | -$11.02K | SELL | -2.44% | 288.55K | Mar 13 | View |
| Jan 27, 2023 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -11.814K | $1.20 | -$14.18K | SELL | -5.60% | 199.225K | Jan 12 | View |
| Sep 19, 2022 | Preetam Shah | CFO & CBO | 34.358K | $0.77 | -$12.03K | SELL-OPTIONS | 29.51% | 150.789K | Sep 15 - Sep 19 | View |
| Sep 13, 2022 | Taylor Sandison | CHIEF MEDICAL OFFICER | -18.478K | $0.68 | -$12.66K | SELL | -5.96% | 291.753K | Sep 12 | View |
| Sep 13, 2022 | Leslie Tari | CHIEF SCIENTIFIC OFFICER | -18.159K | $0.68 | -$12.44K | SELL | -8.06% | 207.039K | Sep 12 | View |
| Sep 13, 2022 | Paul Daruwala | CHIEF OPERATING OFFICER | -16.199K | $0.68 | -$11.09K | SELL | -6.83% | 221.099K | Sep 12 | View |
| Mar 23, 2022 | Brady Johnson | VICE PRESIDENT, FINANCE | -654 | $0.81 | -$529.74 | SELL | -1.31% | 49.366K | Mar 21 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.